PATENT CLAIM ANALYSIS

Application Number: 16059781
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "078310"]

Abstract:
One aspect of the present invention relates generally to injectable compositions. In one embodiment, the compositions include 2-hydroxyethyl methacrylate and a dimethacrylate crosslinker. Another aspect of the invention relates generally to methods of using such compositions for thermal ablation and for the occlusion of body vessels.

Claim (Index 17):
The method of  claim 16 , wherein the cancerous tumor is a tumor of an organ selected from the group consisting of liver, kidney, breast, pancreas, bile duct, lung and bone.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.51515
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10862177', '15106754', '16037572', '11205047', '15704792']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7505591032644492
- 35 USC 102 Novelty (BERT): 0.4798901317755343
- Combined Prediction Score: 0.7234922061155578
- Mean Citation Score: 134.334482
- Max Citation Score: 140.38373
- Similarity Product: 91.72086409773588

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test